Dana Investment Advisors, Inc.

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1427514 BROOKFIELD, WI

Position in LGND

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$18,181,496

+$4,358,928 QoQ

Shares Held

57,520

-16.9% QoQ

Ownership

0.289%

of shares outstanding

% of Portfolio

0.50%

of 13F equity value

Holder Rank

#61

of 415 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 61% Shared 0% None 39%

Healthcare · as of Jun 30, 2026

Dana Investment Advisors, Inc. holds $43,128,971 across 12 Biotechnology names. LGND ranks #1 (42.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc This page	57,520	$18,181,496
2	AXSM	Axsome Therapeutics, Inc.	22,850	$5,592,994
3	REGN	Regeneron Pharmaceuticals, Inc.	7,719	$4,813,105
4	TGTX	Tg Therapeutics, Inc.	42,012	$2,308,139
5	VKTX	Viking Therapeutics, Inc.	57,854	$2,256,884
6	MDGL	Madrigal Pharmaceuticals, Inc.	3,677	$1,974,365
7	ZYME	Zymeworks Inc.	71,660	$1,873,192
8	IONS	Ionis Pharmaceuticals Inc	23,272	$1,845,236

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,181,496	57,520	-16.9%	Shares	Sole	2026-08-13
2026-03-31	$13,822,568	69,234	-0.2%	Shares	Sole	2026-05-14
2025-12-31	$13,120,701	69,396	-4.5%	Shares	Sole	2026-02-05
2025-09-30	$12,870,815	72,659	-0.7%	Shares	Sole	2025-11-10
2025-06-30	$8,317,851	73,169	-1.5%	Shares	Sole	2025-08-13
2025-03-31	$7,813,373	74,314	-2.5%	Shares	Sole	2025-05-15
2024-12-31	$8,167,937	76,229	-5.4%	Shares	Sole	2025-02-06
2024-09-30	$8,067,454	80,602	-10.5%	Shares	Sole	2024-11-13
2024-06-30	$7,588,118	90,056	+18.7%	Shares	Sole	2024-08-27
2024-03-31	$5,544,342	75,846	+323.6%	Shares	Sole	2024-05-15
2020-09-30	$1,706,513	17,903	-6.3%	Shares	Sole	2020-11-10
2020-06-30	$2,137,117	19,107	-7.3%	Shares	Sole	2020-08-11
2020-03-31	$1,498,394	20,605	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.